Authors :
D. K. Vir; Dr. Smita Takarkhede; Jitendra Chouhan; Himanshu Devasi; Ritesh Kanojiya; Harshal Patil
Volume/Issue :
Volume 8 - 2023, Issue 3 - March
Google Scholar :
https://bit.ly/3TmGbDi
Scribd :
https://bit.ly/3z3eeXH
DOI :
https://doi.org/10.5281/zenodo.7758423
Abstract :
Adverse Drug Reactions (ADRs) are a
significant public health concern, and the reporting and
monitoring of these events is essential for the
identification of potential safety issues with medications.
A systemic approach to reporting and monitoring of
ADRs includes a comprehensive evaluation of all aspects
of the process, including the collection and analysis of
ADR data, the reporting mechanisms in place, and the
follow-up and response to the reported events. This
approach should involve collaboration between
healthcare providers, patients, and regulatory agencies,
and should leverage technology to enhance the efficiency
and accuracy of the process. A robust and systematic
approach to ADR reporting and monitoring is critical for
ensuring patient safety and improving the quality of
healthcare.
Adverse Drug Reactions (ADRs) are a
significant public health concern, and the reporting and
monitoring of these events is essential for the
identification of potential safety issues with medications.
A systemic approach to reporting and monitoring of
ADRs includes a comprehensive evaluation of all aspects
of the process, including the collection and analysis of
ADR data, the reporting mechanisms in place, and the
follow-up and response to the reported events. This
approach should involve collaboration between
healthcare providers, patients, and regulatory agencies,
and should leverage technology to enhance the efficiency
and accuracy of the process. A robust and systematic
approach to ADR reporting and monitoring is critical for
ensuring patient safety and improving the quality of
healthcare.
